Last quarter (Q4 2023), Aquestive Therapeutics's total revenue was $13.21M, an increase of 23.63% from the same quarter last year. In Q4, Aquestive Therapeutics's net income was $-8.11M. See Aquestive Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 50.58M	$ 50.58M	$ 47.68M	$ 50.83M	$ 45.85M	$ 52.61M
Cost of Revenue	$ 20.83M	$ 20.83M	-	-	$ 12.96M	$ 20.36M
Gross Profit	$ 29.75M	$ 29.75M	$ 47.68M	$ 50.83M	$ 32.88M	$ 32.25M
Operating Expense	$ 45.81M	$ 45.76M	$ 89.75M	$ -85.51M	$ 75.78M	$ 84.92M
Operating Income	$ -15.15M	$ -15.10M	$ -42.07M	$ -47.09M	$ -42.89M	$ -52.67M
Net Non Operating Interest Income Expense	$ -6.34M	$ -6.34M	$ -6.45M	$ -9.63M	$ -12.89M	$ -8.68M
Other Income Expense	$ 1.38M	$ 1.38M	-	$ 13.82M	-	$ -4.90M
Pretax Income	$ -7.63M	$ -7.63M	$ -54.41M	$ -70.54M	$ -55.78M	$ -66.25M
Tax Provision	$ 245.00K	$ 245.00K	-	-	$ 0.00	$ 0.00
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -9.33M	$ -7.87M	$ -9.75M	$ -70.54M	$ -55.78M	$ -66.25M
Basic EPS	$ -0.10	$ -0.13	$ -1.12	$ -1.85	$ -1.66	$ -2.61
Diluted EPS	$ -0.18	$ -0.13	$ -1.12	$ -1.85	$ -1.66	$ -2.61
Basic Average Shares	$ 245.02M	$ 61.26M	$ 48.73M	$ 38.08M	$ 33.65M	$ 25.36M
Diluted Average Shares	$ 245.02M	$ 61.26M	$ 48.73M	$ 38.08M	$ 33.65M	$ 25.36M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 66.64M	$ 66.59M	$ -89.75M	$ -85.51M	$ 88.74M	$ 105.28M
Net Income From Continuing And Discontinued Operation	$ -7.87M	$ -7.87M	$ -54.41M	$ -70.54M	$ -55.78M	$ -66.25M
Normalized Income	$ -12.78M	$ -5.81M	-	-	$ -55.78M	$ -61.35M
Interest Expense	-	-	-	-	$ 13.02M	$ 9.32M
EBIT	$ -1.29M	$ -1.29M	$ -47.86M	$ -60.49M	$ -42.76M	$ -56.93M
EBITDA	$ 2.03M	$ 2.03M	$ -45.26M	$ -53.80M	$ -39.32M	$ -54.02M

Currency in USD

Aquestive Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing